PMC:7195088 / 59735-60240 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1776","span":{"begin":89,"end":97},"obj":"Species"},{"id":"1777","span":{"begin":190,"end":198},"obj":"Species"},{"id":"1778","span":{"begin":462,"end":470},"obj":"Species"},{"id":"1779","span":{"begin":103,"end":112},"obj":"Species"},{"id":"1780","span":{"begin":21,"end":37},"obj":"Disease"},{"id":"1781","span":{"begin":113,"end":122},"obj":"Disease"},{"id":"1782","span":{"begin":219,"end":228},"obj":"Disease"},{"id":"1783","span":{"begin":387,"end":416},"obj":"Disease"}],"attributes":[{"id":"A1776","pred":"tao:has_database_id","subj":"1776","obj":"Tax:9606"},{"id":"A1777","pred":"tao:has_database_id","subj":"1777","obj":"Tax:9606"},{"id":"A1778","pred":"tao:has_database_id","subj":"1778","obj":"Tax:9606"},{"id":"A1779","pred":"tao:has_database_id","subj":"1779","obj":"Tax:11520"},{"id":"A1780","pred":"tao:has_database_id","subj":"1780","obj":"MESH:D001102"},{"id":"A1781","pred":"tao:has_database_id","subj":"1781","obj":"MESH:D011014"},{"id":"A1782","pred":"tao:has_database_id","subj":"1782","obj":"MESH:D003643"},{"id":"A1783","pred":"tao:has_database_id","subj":"1783","obj":"MESH:D001424"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"With regard to other viral infections, it is worth noting that a recent meta-analysis on patients with influenza pneumonia (including ten observational studies with a total of 6548 included patients) reported increased mortality (risk ratio: 1.75, 95% CI 1.3–2.4; p 0.0002), increased length of ICU stay (mean difference: 2.1, 95% CI 1.2–3.1; p \u003c 0.0001) and increased rate of secondary bacterial or fungal infection (risk ratio: 2.0, 95% CI 1.0–3.8; p 0.04) in patients who received corticosteroids [66]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T100","span":{"begin":113,"end":122},"obj":"Phenotype"}],"attributes":[{"id":"A100","pred":"hp_id","subj":"T100","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"With regard to other viral infections, it is worth noting that a recent meta-analysis on patients with influenza pneumonia (including ten observational studies with a total of 6548 included patients) reported increased mortality (risk ratio: 1.75, 95% CI 1.3–2.4; p 0.0002), increased length of ICU stay (mean difference: 2.1, 95% CI 1.2–3.1; p \u003c 0.0001) and increased rate of secondary bacterial or fungal infection (risk ratio: 2.0, 95% CI 1.0–3.8; p 0.04) in patients who received corticosteroids [66]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T339","span":{"begin":21,"end":37},"obj":"Disease"},{"id":"T340","span":{"begin":103,"end":112},"obj":"Disease"},{"id":"T341","span":{"begin":113,"end":122},"obj":"Disease"},{"id":"T342","span":{"begin":400,"end":416},"obj":"Disease"},{"id":"T343","span":{"begin":407,"end":416},"obj":"Disease"}],"attributes":[{"id":"A339","pred":"mondo_id","subj":"T339","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A340","pred":"mondo_id","subj":"T340","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A341","pred":"mondo_id","subj":"T341","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A342","pred":"mondo_id","subj":"T342","obj":"http://purl.obolibrary.org/obo/MONDO_0002041"},{"id":"A343","pred":"mondo_id","subj":"T343","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"With regard to other viral infections, it is worth noting that a recent meta-analysis on patients with influenza pneumonia (including ten observational studies with a total of 6548 included patients) reported increased mortality (risk ratio: 1.75, 95% CI 1.3–2.4; p 0.0002), increased length of ICU stay (mean difference: 2.1, 95% CI 1.2–3.1; p \u003c 0.0001) and increased rate of secondary bacterial or fungal infection (risk ratio: 2.0, 95% CI 1.0–3.8; p 0.04) in patients who received corticosteroids [66]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T329","span":{"begin":63,"end":64},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T330","span":{"begin":134,"end":137},"obj":"http://purl.obolibrary.org/obo/CLO_0050884"},{"id":"T331","span":{"begin":165,"end":166},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"With regard to other viral infections, it is worth noting that a recent meta-analysis on patients with influenza pneumonia (including ten observational studies with a total of 6548 included patients) reported increased mortality (risk ratio: 1.75, 95% CI 1.3–2.4; p 0.0002), increased length of ICU stay (mean difference: 2.1, 95% CI 1.2–3.1; p \u003c 0.0001) and increased rate of secondary bacterial or fungal infection (risk ratio: 2.0, 95% CI 1.0–3.8; p 0.04) in patients who received corticosteroids [66]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T70959","span":{"begin":484,"end":499},"obj":"Chemical"}],"attributes":[{"id":"A89095","pred":"chebi_id","subj":"T70959","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":"With regard to other viral infections, it is worth noting that a recent meta-analysis on patients with influenza pneumonia (including ten observational studies with a total of 6548 included patients) reported increased mortality (risk ratio: 1.75, 95% CI 1.3–2.4; p 0.0002), increased length of ICU stay (mean difference: 2.1, 95% CI 1.2–3.1; p \u003c 0.0001) and increased rate of secondary bacterial or fungal infection (risk ratio: 2.0, 95% CI 1.0–3.8; p 0.04) in patients who received corticosteroids [66]."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T28","span":{"begin":21,"end":37},"obj":"http://purl.obolibrary.org/obo/GO_0016032"}],"text":"With regard to other viral infections, it is worth noting that a recent meta-analysis on patients with influenza pneumonia (including ten observational studies with a total of 6548 included patients) reported increased mortality (risk ratio: 1.75, 95% CI 1.3–2.4; p 0.0002), increased length of ICU stay (mean difference: 2.1, 95% CI 1.2–3.1; p \u003c 0.0001) and increased rate of secondary bacterial or fungal infection (risk ratio: 2.0, 95% CI 1.0–3.8; p 0.04) in patients who received corticosteroids [66]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T436","span":{"begin":0,"end":241},"obj":"Sentence"},{"id":"T437","span":{"begin":242,"end":321},"obj":"Sentence"},{"id":"T438","span":{"begin":322,"end":429},"obj":"Sentence"},{"id":"T439","span":{"begin":430,"end":505},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"With regard to other viral infections, it is worth noting that a recent meta-analysis on patients with influenza pneumonia (including ten observational studies with a total of 6548 included patients) reported increased mortality (risk ratio: 1.75, 95% CI 1.3–2.4; p 0.0002), increased length of ICU stay (mean difference: 2.1, 95% CI 1.2–3.1; p \u003c 0.0001) and increased rate of secondary bacterial or fungal infection (risk ratio: 2.0, 95% CI 1.0–3.8; p 0.04) in patients who received corticosteroids [66]."}

{"project":"2_test","denotations":[{"id":"32360444-30917856-22369806","span":{"begin":501,"end":503},"obj":"30917856"}],"text":"With regard to other viral infections, it is worth noting that a recent meta-analysis on patients with influenza pneumonia (including ten observational studies with a total of 6548 included patients) reported increased mortality (risk ratio: 1.75, 95% CI 1.3–2.4; p 0.0002), increased length of ICU stay (mean difference: 2.1, 95% CI 1.2–3.1; p \u003c 0.0001) and increased rate of secondary bacterial or fungal infection (risk ratio: 2.0, 95% CI 1.0–3.8; p 0.04) in patients who received corticosteroids [66]."}